Live Online Training: Virus and TSE Safety made simple

Live Online Training: Virus and TSE Safety made simple

Course No 18652

All times mentioned are CET.

Costs

There is unfortunately no recording available for this Online Training Course. However, are you interested in participating in an upcoming Live Online date of this Training Course? Or do you need any assistance on our Training Courses & Conference programme? Then simply use the following contact form to send us your request.

If you have any questions, please contact us:
Tel.: +49 (0)6221 / 84 44 0 E-Mail: info@gmp-compliance.org

Speakers

Dr Johannes Blümel, Paul-Ehrlich-Institut, Federal Agency Vaccines and Biomedicines
Dr Albrecht Gröner, PathoGuard Consult
Dr Michael Ruffing, Boehringer Ingelheim Pharma

Objectives

The current situation has shown us that the development and production of vaccines can also attract enormous public attention. This makes it all the more important, especially when it comes to approval and production under time pressure, that the quality standards of good manufacturing practice are observed
Virus safety is one of the major concerns in the development and production of biopharmaceuticals and biologics. Huge efforts are undertaken to prevent viral contamination. A series of guidelines was dedicated to that topic exclusively.

For many people who are involved in the development and production of biopharmaceuticals and biologics the world of viruses is a “black box”.
It is the aim of this Live Online Training to enlighten this world between “dead and alive”.

The nature of viruses postulates significant differences to micro-organisms. This uniqueness poses particular challenges to the detection, inactivation and removal of viruses.

All these specifics will be discussed in detail at this education course – in an understandable manner.

Another threat poses TSE (Transmissible spongiform encephalopathy). Numerous studies have been conducted to understand the route of transmission and the causing agents better. Nevertheless, misunderstandings and rumours circulate and cumulate in the statement: “We need a TSE-certificate for our activated charcoal.”

This Live Online Training will give you a scientifically sound introduction into the field of TSE and the impact on the pharmaceutical industry.

Target Group

The Live Online Training is directed to responsible personnel involved in the development and production of biopharmaceuticals and biologics
  • Research & Development
  • Quality Assurance
  • Regulatory Affairs
  • Production
  • Engineering
  • Quality Control
It is also useful for service providers, such as contract research organisations and contract manufacturers.

Technical Requirements

For our Live Online Training Courses and Webinars, we use Cisco WebEx, one of the leading suppliers of online meetings.

At http://www.webex.com/test-meeting.html you can check if your system meets the necessary requirements for the participation at a WebEx meeting and at the same time install the necessary plug-in.  Please just enter your name and email address for the test. If the installation is not possible because of your rights for the computer system, please contact your IT department. WebEx is a standard nowadays and the necessary installation is fast and easy.

Programme

Elemental (Basic) Virology
  • Physiology (if you can use such a word)
  • Replication cycles
  • Vectors
  • Resistance properties
Exogenous (Adventitious) and Endogenous Virus
  • Terminology
  • Viral safety approach
  • Effects of virus infection on host cell
  • Detection of exogenous / endogenous virus
Virus Safety of Raw Materials
  • Qualification of the material and its supplier
  • Sourcing, testing and manufacture of raw materials
  • Virus clearance studies
  • Testing prior and at production of biotech product
Design and Documentation of Virus Validation Studies
  • Sources
  • Virus spike preparation
  • Cytotoxicity/Interference
  • Infectivity assay or NAT assay
  • Down scaling of manufacturing step
Methods for Virus Inactivation and Virus Removal
  • Virus reduction by manufacturing process steps for protein purification
  • Virus reduction by dedicated virus reduction steps
  • Robustness of virus reduction methods
  •  Facility segregation to avoid cross-contamination of product intermediates
Virus Safety Aspects of Advanced Therapy Medicinal Products (ATMPs)
Regulatory background/certification
Gene therapy medicinal products
Cell-based medicinal products
 
Virus Safety: Regulatory Background
  • ICH Guidelines (ICH Q5A)
  • European Guidelines (EMEA)
  • European Pharmacopoeia
  • Risk assessment
  • Clinical trials in Europe
Transmissible Spongiform Encephalopathy (TSE) - Biology
  • The nature and transmission of TSE-agents (prions)
  • Epidemiology
  • Methods for detecting TSE agents
  • Resistance/inactivation of prions, cleaning/disinfection
  • Prion reduction techniques
Transmissible Spongiform Encephalopathy (TSE) - Regulatory
  • EU-Legislation (food, medicinal products, medicinal devices)
  • EMEA TSE note for guidance
  • EDQM TSE Certification Procedure
  • Regulations for blood and urine derived medicinal products
Case Studies and Examples  for Assessing Approaches to Manufacture Pathogen Safe Products
In this section of the training all trainers will use case studies and examples to show you different approaches to dealing with problems in vaccine/niopharmaceutical  production.

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK